抗生素耐药性与感染治疗
Antibiotic Resistance and Therapy for Infection.
作者信息
Smith Stella I, Yamaoka Yoshio
机构信息
Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos 100001, Nigeria.
Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Idaigaoka, Hasama-machi, Yufu 879-5593, Japan.
出版信息
Antibiotics (Basel). 2023 Nov 28;12(12):1669. doi: 10.3390/antibiotics12121669.
Abstract
Approximately half of the world's population is estimated to be infected with [...].
摘要
据估计，世界上约一半的人口感染了[…]。
相似文献
1
Antibiotic Resistance and Therapy for Infection.抗生素耐药性与感染治疗
Antibiotics (Basel). 2023 Nov 28;12(12):1669. doi: 10.3390/antibiotics12121669.
2
Current paradigms in the management of refractory Helicobacter pylori infection.难治性幽门螺杆菌感染的当前管理范式。
Indian J Gastroenterol. 2023 Dec;42(6):766-779. doi: 10.1007/s12664-023-01448-3. Epub 2023 Sep 22.
3
Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Infection.对抗抗生素危机：类黄酮作为有前途的抗感染抗菌药物。
Front Cell Infect Microbiol. 2021 Jul 20;11:709749. doi: 10.3389/fcimb.2021.709749. eCollection 2021.
4
Antibiotic Resistance and Therapeutic Efficacy of Infection in Pediatric Patients-A Tertiary Center Experience.儿科患者感染的抗生素耐药性与治疗效果——三级医疗中心经验
Antibiotics (Basel). 2023 Jan 11;12(1):146. doi: 10.3390/antibiotics12010146.
5
Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance.幽门螺杆菌感染：在全球抗生素耐药性日益增加的时代，内科医生的最新认识。
Am J Med. 2018 May;131(5):473-479. doi: 10.1016/j.amjmed.2017.12.024. Epub 2018 Jan 17.
6
Antibiotic Resistance in Egypt: A Single-Center Study.埃及的抗生素耐药性：一项单中心研究。
Infect Drug Resist. 2022 Oct 11;15:5905-5913. doi: 10.2147/IDR.S386082. eCollection 2022.
7
Drug-Resistant : Diagnosis and Evidence-Based Approach.耐药性：诊断与循证方法
Diagnostics (Basel). 2023 Sep 14;13(18):2944. doi: 10.3390/diagnostics13182944.
8
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.N-乙酰半胱氨酸作为幽门螺杆菌根除的辅助治疗。
Cochrane Database Syst Rev. 2019 Feb 12;2(2):CD012357. doi: 10.1002/14651858.CD012357.pub2.
9
The impacts of probiotics in eradication therapy of Helicobacter pylori.益生菌对幽门螺杆菌根除治疗的影响。
Arch Microbiol. 2022 Nov 7;204(12):692. doi: 10.1007/s00203-022-03314-w.
10
Bacteriophages of .……的噬菌体
Front Microbiol. 2020 Nov 12;11:549084. doi: 10.3389/fmicb.2020.549084. eCollection 2020.
引用本文的文献
1
Chebulinic acid isolated from aqueous extracts of Retz inhibits infection by potential binding to Cag A protein and regulating adhesion.从诃子水提取物中分离出的诃子林檎酸通过与Cag A蛋白潜在结合并调节黏附来抑制感染。
Front Microbiol. 2024 Oct 2;15:1416794. doi: 10.3389/fmicb.2024.1416794. eCollection 2024.
2
Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.通过计算方法，利用大豆苷元衍生物鉴定幽门螺杆菌致癌 TNF-α诱导蛋白抑制剂。
J Cell Mol Med. 2024 May;28(9):e18358. doi: 10.1111/jcmm.18358.
3
1,3,6-Trigalloylglucose: A Novel Potent Anti- Adhesion Agent Derived from Aqueous Extracts of Retz.1,3,6-三没食子酰葡萄糖：一种源自Retz.水提取物的新型强效抗黏附剂
Molecules. 2024 Mar 5;29(5):1161. doi: 10.3390/molecules29051161.
4
: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies.发病机制、诊断与治疗策略的当代视角
Microorganisms. 2024 Jan 22;12(1):222. doi: 10.3390/microorganisms12010222.
本文引用的文献
1
Treatment of infection and gastric ulcer: Need for novel Pharmaceutical formulation.感染与胃溃疡的治疗：新型药物制剂的需求
Heliyon. 2023 Sep 24;9(10):e20406. doi: 10.1016/j.heliyon.2023.e20406. eCollection 2023 Oct.
2
Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections.姜黄素克拉霉素纳米制剂有望成为治疗幽门螺杆菌感染的药物。
World J Microbiol Biotechnol. 2023 Sep 29;39(12):324. doi: 10.1007/s11274-023-03745-7.
3
Drug-Resistant : Diagnosis and Evidence-Based Approach.耐药性：诊断与循证方法
Diagnostics (Basel). 2023 Sep 14;13(18):2944. doi: 10.3390/diagnostics13182944.
4
Control of with engineered probiotics secreting selective guided antimicrobial peptides.利用分泌选择性导向抗菌肽的工程益生菌进行控制。
Microbiol Spectr. 2023 Sep 15;11(5):e0201423. doi: 10.1128/spectrum.02014-23.
5
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori Infection.基于纳米技术的未来策略，改善幽门螺杆菌感染的管理。
Small. 2024 Jan;20(3):e2302532. doi: 10.1002/smll.202302532. Epub 2023 Sep 11.
6
Antibiotic Resistance: Molecular Basis and Diagnostic Methods.抗生素耐药性：分子基础与诊断方法。
Int J Mol Sci. 2023 May 29;24(11):9433. doi: 10.3390/ijms24119433.
7
Antibiotic Resistance and Therapy for Infection in Immigrant Patients Treated in Italy.意大利接受治疗的移民患者感染的抗生素耐药性与治疗
J Clin Med. 2020 May 1;9(5):1299. doi: 10.3390/jcm9051299.
Zotero 插件